Oxaliplatin Injection, Solution, Concentrate
Product Images NDC 63323-750

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxaliplatin (NDC 63323-750). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxa0p 0001 01

FDA Label Image

Oxa0p 0001 02

FDA Label Image

Oxa0p 0001 03

FDA Label Image

Oxa0p 0001 04

FDA Label Image

Oxa0p 0001 05

FDA Label Image

Oxa0p 0001 06

FDA Label Image

Oxa0p 0001 07

Oxa0p 0001 07
This is a medication called Oxaliplatin, which is an injection used for intravenous use only. Each vial contains 50mg of the substance in 10mL of solution (5mg per mL). Before administering it, the solution must be diluted with 5% dextrose injection. This medication should not be mixed with or added to sodium chloride/chloride-containing solutions. It is a preservative-free cytotoxic agent. The text mentions an NDC code of 63323-750-10 and a single-dose vial from Fresenius.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.